Recent Updates
Recently added Catalysts
MYO Positive Sentiment

Myomo, Inc. Announces the Launch of Myomo Academy at AOPA National Assembly

Thursday, September 12, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Myomo, Inc. has launched the Myomo Academy, a new learning management system aimed at professionals in the Orthotics & Prosthetics and Rehabilitation fields. This initiative is designed to improve the training and resources available for those working with individuals suffering from neurological disorders and upper-limb paralysis. The launch was announced during the AOPA National Assembly.
Price reaction · baseline $4.08 (2024-09-11 close) · hit pre-market · clean, no other MYO news in the window
day 0 close · peak
+0.5%

Market Sentiment Analysis

POSITIVE FACTORS

  • Launch of Myomo Academy enhances professional training.
  • Focus on Orthotics & Prosthetics and Rehabilitation sectors.
  • Supports individuals with neurological disorders and paralysis.

Full Press Release Details

BOSTON (September 12, 2024) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced the official launch of the Myomo Academy , a comprehensive learning management system for professionals in Orthotics & Prosthetics (O&P) and Rehabilitation. Read more .

Frequently Asked Questions

What is Myomo Academy?

Myomo Academy is a learning management system for professionals in Orthotics & Prosthetics and Rehabilitation.

When was Myomo Academy launched?

Myomo Academy was officially launched on September 12, 2024.

What is the focus of Myomo Academy?

The focus is on enhancing training for professionals working with neurological disorders and upper-limb paralysis.

Where was the launch of Myomo Academy announced?

The launch was announced at the AOPA National Assembly.

ShareAdd on Google
Tags: MYO Viatris Investor Conferences Healthcare Myomo AOPA National Assembly Orthotics Prosthetics Rehabilitation
Last updated: Sep 12, 2024

Biotech snapshot

Cash runway
$13M liquidity · $1M/mo burn
~20 mo
Low dilution risk